Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 8.98M | $ 7.50M | $ 13.08M | $ 2.92M | $ 5.01M |
Total Assets | $ 57.55M | $ 55.38M | $ 54.97M | $ 20.12M | $ 22.95M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 20.41M | $ 13.11M | $ 10.23M | $ 3.66M | $ 2.48M |
Stockholders Equity | $ 37.15M | $ 42.27M | $ 44.74M | $ 16.47M | $ 20.47M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |